Emerging biologic therapies for systemic lupus erythematosus.
Hiroshi KatoJ Michelle Kahlenberg
Published in: Current opinion in rheumatology (2024)
While many drug candidates which met the end points in phase II trials have failed phase III trials, the number of target-specific therapies for SLE has continued to expand.